The results showed that both the volumes and weights of formed CRC tumor nodes were reduced by anti-TIGIT or sulfarotene, which could be further augmented by the combination of treatment with anti-TIGIT and sulfarotene (Figure 5B–E). The gene discussed is TIGIT; the disease is colorectal carcinoma.